{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T11:11:36Z","timestamp":1768734696990,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Clin Pharmacol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1472-6904-9-13","type":"journal-article","created":{"date-parts":[[2009,8,4]],"date-time":"2009-08-04T06:13:39Z","timestamp":1249366419000},"source":"Crossref","is-referenced-by-count":7,"title":["A Phase 1 Trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion"],"prefix":"10.1186","volume":"9","author":[{"given":"Debra S","family":"Harris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Everhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Peyton","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emil","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E","family":"Mendelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reese T","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,1]]},"reference":[{"issue":"5335","key":"75_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1126\/science.278.5335.52","volume":"278","author":"GF Koob","year":"1997","unstructured":"Koob GF, Le Moal M: Drug abuse: hedonic homeostatic dysregulation. Science. 1997, 278 (5335): 52-58. 10.1126\/science.278.5335.52.","journal-title":"Science"},{"issue":"3","key":"75_CR2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/0149-7634(85)90022-3","volume":"9","author":"CA Dackis","year":"1985","unstructured":"Dackis CA, Gold MS: New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci Biobehav Rev. 1985, 9 (3): 469-477. 10.1016\/0149-7634(85)90022-3.","journal-title":"Neurosci Biobehav Rev"},{"issue":"6 Suppl 3","key":"75_CR3","doi-asserted-by":"publisher","first-page":"S137","DOI":"10.1212\/WNL.47.6_Suppl_3.137S","volume":"47","author":"M Gerlach","year":"1996","unstructured":"Gerlach M, Youdim MB, Riederer P: Pharmacology of selegiline. Neurology. 1996, 47 (6 Suppl 3): S137-145.","journal-title":"Neurology"},{"issue":"3","key":"75_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.drugalcdep.2006.04.010","volume":"85","author":"A Elkashef","year":"2006","unstructured":"Elkashef A, Fudala PJ, Gorgon L, Li SH, Kahn R, Chiang N, Vocci F, Collins J, Jones K, Boardman K, et al: Double-blind, placebo-controlled trial of selegiline transdermal system (STS) for the treatment of cocaine dependence. Drug Alcohol Depend. 2006, 85 (3): 191-197. 10.1016\/j.drugalcdep.2006.04.010.","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"75_CR5","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1097\/00045391-199610000-00004","volume":"3","author":"JS Barrett","year":"1996","unstructured":"Barrett JS, Hochadel TJ, Morales RJ, Rohatagi S, DeWitt KE, Watson SK, DiSanto AR: Pharmacokinetics and Safety of a Selegiline Transdermal System Relative to Single-Dose Oral Administration in the Elderly. Am J Ther. 1996, 3 (10): 688-698. 10.1097\/00045391-199610000-00004.","journal-title":"Am J Ther"},{"issue":"1","key":"75_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2174\/0929867023371481","volume":"9","author":"D Haberle","year":"2002","unstructured":"Haberle D, Szoko E, Magyar K: The influence of metabolism on the MAO-B inhibitory potency of selegiline. Curr Med Chem. 2002, 9 (1): 47-51.","journal-title":"Curr Med Chem"},{"issue":"2","key":"75_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/(SICI)1099-081X(199703)18:2<165::AID-BDD14>3.0.CO;2-S","volume":"18","author":"JS Barrett","year":"1997","unstructured":"Barrett JS, DiSanto AR, Thomford PJ, Larsen EM, Palazzolo MJ, Morales RJ: Toxicokinetic evaluation of a selegiline transdermal system in the dog. Biopharm Drug Dispos. 1997, 18 (2): 165-184. 10.1002\/(SICI)1099-081X(199703)18:2<165::AID-BDD14>3.0.CO;2-S.","journal-title":"Biopharm Drug Dispos"},{"issue":"1","key":"75_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0376-8716(95)01137-N","volume":"39","author":"KA Haberny","year":"1995","unstructured":"Haberny KA, Walsh SL, Ginn DH, Wilkins JN, Garner JE, Setoda D, Bigelow GE: Absence of acute cocaine interactions with the MAO-B inhibitor selegiline. Drug Alcohol Depend. 1995, 39 (1): 55-62. 10.1016\/0376-8716(95)01137-N.","journal-title":"Drug Alcohol Depend"},{"issue":"2\u20133","key":"75_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0165-1781(99)00058-X","volume":"87","author":"TF Newton","year":"1999","unstructured":"Newton TF, Kalechstein A, Beckson M, Bartzokis G, Bridge TP, Ling W: Effects of selegiline pretreatment on response to experimental cocaine administration. Psychiatry Res. 1999, 87 (2\u20133): 101-106. 10.1016\/S0165-1781(99)00058-X.","journal-title":"Psychiatry Res"},{"issue":"6","key":"75_CR10","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S0893-133X(98)00092-X","volume":"20","author":"G Bartzokis","year":"1999","unstructured":"Bartzokis G, Beckson M, Newton T, Mandelkern M, Mintz J, Foster JA, Ling W, Bridge TP: Selegiline effects on cocaine-induced changes in medial temporal lobe metabolism and subjective ratings of euphoria. Neuropsychopharmacology. 1999, 20 (6): 582-590. 10.1016\/S0893-133X(98)00092-X.","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"75_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00213-003-1616-6","volume":"172","author":"EJ Houtsmuller","year":"2004","unstructured":"Houtsmuller EJ, Notes LD, Newton T, van Sluis N, Chiang N, Elkashef A, Bigelow GE: Transdermal selegiline and intravenous cocaine: safety and interactions. Psychopharmacology (Berl). 2004, 172 (1): 31-40. 10.1007\/s00213-003-1616-6.","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"75_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/schbul\/18.1.123","volume":"18","author":"F Amin","year":"1992","unstructured":"Amin F, Davidson M, Davis KL: Homovanillic acid measurement in clinical research: a review of methodology. Schizophr Bull. 1992, 18 (1): 123-148.","journal-title":"Schizophr Bull"},{"issue":"1","key":"75_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/BF01245022","volume":"80","author":"L Peyrin","year":"1990","unstructured":"Peyrin L: Urinary MHPG sulfate as a marker of central norepinephrine metabolism: a commentary. J Neural Transm Gen Sect. 1990, 80 (1): 51-65. 10.1007\/BF01245022.","journal-title":"J Neural Transm Gen Sect"},{"issue":"9","key":"75_CR14","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/S0196-0644(82)80067-X","volume":"11","author":"S Smookler","year":"1982","unstructured":"Smookler S, Bermudez AJ: Hypertensive crisis resulting from an MAO inhibitor and an over-the-counter appetite suppressant. Ann Emerg Med. 1982, 11 (9): 482-484U. 10.1016\/S0196-0644(82)80067-X.","journal-title":"Ann Emerg Med"},{"issue":"14","key":"75_CR15","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/0024-3205(96)00428-6","volume":"59","author":"NA Darmani","year":"1996","unstructured":"Darmani NA: Differential potentiation of L-tryptophan-induced head-twitch response in mice by cocaine and sertraline. Life Sci. 1996, 59 (14): 1109-1119. 10.1016\/0024-3205(96)00428-6.","journal-title":"Life Sci"},{"key":"75_CR16","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1192\/bjp.163.6.815","volume":"163","author":"C Brewer","year":"1993","unstructured":"Brewer C: Treatment of cocaine abuse with monoamine oxidase inhibitors. Br J Psychiatry. 1993, 163: 815-816. 10.1192\/bjp.163.6.815.","journal-title":"Br J Psychiatry"},{"issue":"7","key":"75_CR17","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/0006-2952(68)90066-X","volume":"17","author":"JP Johnston","year":"1968","unstructured":"Johnston JP: Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem Pharmacol. 1968, 17 (7): 1285-1297. 10.1016\/0006-2952(68)90066-X.","journal-title":"Biochem Pharmacol"},{"key":"75_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/978-1-4612-4602-2_20","volume-title":"Trace Amines: Comparative and Clinical Neurobiology","author":"DP Henry","year":"1988","unstructured":"Henry DP, Russell WI, Clemens JA, Plebus LA: Phenylethylamine and p-tyramine in the extracellular space of the rat brain: quantification using a new radioenzymatic assay and in situ microdialysis. Trace Amines: Comparative and Clinical Neurobiology. Edited by: Boulton AA, Juorio AV, Downer RGH. 1988, Clifton, NJ: Humana Press, 239-250."},{"issue":"6","key":"75_CR19","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1111\/j.1471-4159.1990.tb05764.x","volume":"55","author":"IA Paterson","year":"1990","unstructured":"Paterson IA, Juorio AV, Boulton AA: 2-Phenylethylamine: a modulator of catecholamine transmission in the mammalian central nervous system?. J Neurochem. 1990, 55 (6): 1827-1837. 10.1111\/j.1471-4159.1990.tb05764.x.","journal-title":"J Neurochem"},{"issue":"1","key":"75_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0024-3205(91)90581-U","volume":"49","author":"M Scheinin","year":"1991","unstructured":"Scheinin M, Karhuvaara S, Ojala-Karlsson P, Kallio A, Koulu M: Plasma 3,4-dihydroxyphenylglycol (DHPG) and 3-methoxy-4-hydroxyphenylglycol (MHPG) are insensitive indicators of alpha 2-adrenoceptor mediated regulation of norepinephrine release in healthy human volunteers. Life Sci. 1991, 49 (1): 75-84. 10.1016\/0024-3205(91)90581-U.","journal-title":"Life Sci"},{"key":"75_CR21","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1002\/(SICI)1099-1344(19991230)42:13<1265::AID-JLCR283>3.0.CO;2-Y","volume":"42","author":"ET Everhart","year":"1999","unstructured":"Everhart ET, Jacob P, Mendelson J, Jones RT: The synthesis of deuterium-labeled cocaine, cocaethylene and metabolites. J Labelled Cpd Radiopharm. 1999, 42: 1265-1275. 10.1002\/(SICI)1099-1344(19991230)42:13<1265::AID-JLCR283>3.0.CO;2-Y.","journal-title":"J Labelled Cpd Radiopharm"},{"issue":"Suppl","key":"75_CR22","first-page":"502","volume":"13","author":"S Rohatagi","year":"1996","unstructured":"Rohatagi S, Barrett JS, DeWitt KE, Morales RJ: Multiple dose pharmacokinetics and dose proportionality of selegiline and metabolites in healthy males following transdermal administration (Abstr). Pharm Res. 1996, 13 (Suppl): 502-","journal-title":"Pharm Res"},{"issue":"1","key":"75_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1300\/J069v21n01_04","volume":"21","author":"SL Simon","year":"2002","unstructured":"Simon SL, Richardson K, Dacey J, Glynn S, Domier CP, Rawson RA, Ling W: A comparison of patterns of methamphetamine and cocaine use. J Addict Dis. 2002, 21 (1): 35-44. 10.1300\/J069v21n01_04.","journal-title":"J Addict Dis"},{"key":"75_CR24","unstructured":"Alberta Health Service: Beyond the ABCs \u2013 Cocaine. [ http:\/\/www.aadac.com\/87_417.asp ]"},{"issue":"2","key":"75_CR25","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/j.1471-4159.1987.tb02895.x","volume":"49","author":"CD Arnett","year":"1987","unstructured":"Arnett CD, Fowler JS, MacGregor RR, Schlyer DJ, Wolf AP, Langstrom B, Halldin C: Turnover of brain monoamine oxidase measured in vivo by positron emission tomography using L-[11C]deprenyl. J Neurochem. 1987, 49 (2): 522-527. 10.1111\/j.1471-4159.1987.tb02895.x.","journal-title":"J Neurochem"},{"key":"75_CR26","volume-title":"EITS Manual for the Profile of Mood States","author":"DM McNair","year":"1971","unstructured":"McNair DM, Lorr M, Droppleman LF: EITS Manual for the Profile of Mood States. 1971, San Diego, CA: Educational and Industrial Testing Service"},{"issue":"2","key":"75_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0378-4347(87)80121-4","volume":"417","author":"P Jacob 3rd","year":"1987","unstructured":"Jacob P, Elias-Baker BA, Jones RT, Benowitz NL: Determination of benzoylecgonine and cocaine in biologic fluids by automated gas chromatography. J Chromatogr. 1987, 417 (2): 277-286.","journal-title":"J Chromatogr"},{"key":"75_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0378-4347(84)80195-4","volume":"308","author":"A Minegishi","year":"1984","unstructured":"Minegishi A, Ishizaki T: Rapid and simple method for the simultaneous determination of 3,4-dihydroxyphenylacetic acid, 5-hydroxyindole-3-acetic acid and 4-hydroxy-3-methoxyphenylacetic acid in human plasma by high-performance liquid chromatography with electrochemical detection. J Chromatogr. 1984, 308: 55-63. 10.1016\/0378-4347(84)80195-4.","journal-title":"J Chromatogr"},{"issue":"20","key":"75_CR29","doi-asserted-by":"publisher","first-page":"5290","DOI":"10.1021\/ac020101a","volume":"74","author":"P Jacob 3rd","year":"2002","unstructured":"Jacob P, Wilson M, Yu L, Mendelson J, Jones RT: Determination of 4-hydroxy-3-methoxyphenylethylene glycol 4-sulfate in human urine using liquid chromatography-tandem mass spectrometry. Anal Chem. 2002, 74 (20): 5290-5296. 10.1021\/ac020101a.","journal-title":"Anal Chem"},{"key":"75_CR30","volume-title":"Pharmacokinetics","year":"1982","unstructured":"Gibaldi M, Perrier D, Eds: Pharmacokinetics. 1982, New York, NY: Marcel Dekker, 2","edition":"2"},{"key":"75_CR31","unstructured":"WinNonlin Pro. 1999, Mountain View, CA: Pharsight Corporation, 3.0"},{"issue":"2","key":"75_CR32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0376-8716(03)00200-X","volume":"72","author":"DS Harris","year":"2003","unstructured":"Harris DS, Everhart ET, Mendelson J, Jones RT: The pharmacology of cocaethylene in humans following cocaine and ethanol administration. Drug Alcohol Depend. 2003, 72 (2): 169-182. 10.1016\/S0376-8716(03)00200-X.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"75_CR33","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0022-3565(25)21159-4","volume":"279","author":"SL Walsh","year":"1996","unstructured":"Walsh SL, Sullivan JT, Preston KL, Garner JE, Bigelow GE: Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans. J Pharmacol Exp Ther. 1996, 279 (2): 524-538.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"75_CR34","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0376-8716(01)00129-6","volume":"64","author":"SM Evans","year":"2001","unstructured":"Evans SM, Walsh SL, Levin FR, Foltin RW, Fischman MW, Bigelow GE: Effect of flupenthixol on subjective and cardiovascular responses to intravenous cocaine in humans. Drug Alcohol Depend. 2001, 64 (3): 271-283. 10.1016\/S0376-8716(01)00129-6.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"75_CR35","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S0893-133X(00)00130-5","volume":"23","author":"A Gamma","year":"2000","unstructured":"Gamma A, Buck A, Berthold T, Liechti ME, Vollenweider FX: 3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2)(15)O]-PET in healthy humans. Neuropsychopharmacology. 2000, 23 (4): 388-395. 10.1016\/S0893-133X(00)00130-5.","journal-title":"Neuropsychopharmacology"},{"issue":"4\u20136","key":"75_CR36","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/0278-5846(84)90023-X","volume":"8","author":"AJ Greenshaw","year":"1984","unstructured":"Greenshaw AJ: beta-Phenylethylamine and reinforcement. Prog Neuropsychopharmacol Biol Psychiatry. 1984, 8 (4\u20136): 615-620. 10.1016\/0278-5846(84)90023-X.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"75_CR37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s002130100890","volume":"159","author":"J Bergman","year":"2001","unstructured":"Bergman J, Yasar S, Winger G: Psychomotor stimulant effects of beta-phenylethylamine in monkeys treated with MAO-B inhibitors. Psychopharmacology (Berl). 2001, 159 (1): 21-30. 10.1007\/s002130100890.","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"75_CR38","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/0091-3057(80)90273-7","volume":"13","author":"FC Colpaert","year":"1980","unstructured":"Colpaert FC, Niemegeers CJ, Janssen PA: Evidence that a preferred substrate for type B monoamine oxidase mediates stimulus properties of MAO inhibitors: a possible role for beta-phenylethylamine in the cocaine cue. Pharmacol Biochem Behav. 1980, 13 (4): 513-517. 10.1016\/0091-3057(80)90273-7.","journal-title":"Pharmacol Biochem Behav"},{"issue":"9\u201310","key":"75_CR39","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/00045391-199709000-00009","volume":"4","author":"F Karoum","year":"1997","unstructured":"Karoum F, Wolf ME, Mosnaim AD: Effects of the administration of amphetamine, either alone or in combination with reserpine or cocaine, on regional brain beta-phenylethylamine and dopamine release. Am J Ther. 1997, 4 (9\u201310): 333-342.","journal-title":"Am J Ther"},{"issue":"1","key":"75_CR40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/syn.10183","volume":"48","author":"WK Schiffer","year":"2003","unstructured":"Schiffer WK, Azmoodeh M, Gerasimov M, Volkow ND, Fowler JS, Dewey SL: Selegiline potentiates cocaine-induced increases in rodent nucleus accumbens dopamine. Synapse. 2003, 48 (1): 35-38. 10.1002\/syn.10183.","journal-title":"Synapse"},{"issue":"9","key":"75_CR41","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/BF00966762","volume":"18","author":"PR Paetsch","year":"1993","unstructured":"Paetsch PR, Greenshaw AJ: 2-Phenylethylamine-induced changes in catecholamine receptor density: implications for antidepressant drug action. Neurochem Res. 1993, 18 (9): 1015-1022. 10.1007\/BF00966762.","journal-title":"Neurochem Res"},{"key":"75_CR42","first-page":"119","volume":"29","author":"AA Boulton","year":"1990","unstructured":"Boulton AA, Juorio AV, Paterson IA: Phenylethylamine in the CNS: effects of monoamine oxidase inhibiting drugs, deuterium substitution and lesions and its role in the neuromodulation of catecholaminergic neurotransmission. J Neural Transm Suppl. 1990, 29: 119-129.","journal-title":"J Neural Transm Suppl"},{"issue":"10","key":"75_CR43","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S0006-3223(02)01892-9","volume":"54","author":"L Wecker","year":"2003","unstructured":"Wecker L, James S, Copeland N, Pacheco MA: Transdermal selegiline: targeted effects on monoamine oxidases in the brain. Biol Psychiatry. 2003, 54 (10): 1099-1104. 10.1016\/S0006-3223(02)01892-9.","journal-title":"Biol Psychiatry"}],"container-title":["BMC Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6904-9-13.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6904-9-13\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6904-9-13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6904-9-13.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T16:26:33Z","timestamp":1739291193000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1186\/1472-6904-9-13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["75"],"URL":"https:\/\/doi.org\/10.1186\/1472-6904-9-13","relation":{},"ISSN":["1472-6904"],"issn-type":[{"value":"1472-6904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,1]]},"article-number":"13"}}